spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR002401 Cytochrome P450, E-class, group I

Protein matchesHelp
UniProtKB
Matches:
11723 proteins
AccessionHelp IPR002401 Cyt_P450_E_grp-I
TypeHelp Family
SignaturesHelp
InterPro RelationshipsHelp
Parent IPR001128 Cytochrome P450
Children IPR008066 Cytochrome P450, E-class, group I, CYP1
IPR008067 Cytochrome P450, E-class, group I, CYP2A-like
IPR008068 Cytochrome P450, E-class, group I, CYP2B-like
IPR008069 Cytochrome P450, E-class, group I, CYP2D-like
IPR008070 Cytochrome P450, E-class, group I, CYP2E-like
IPR008071 Cytochrome P450, E-class, group I, CYP2J-like
IPR020469 Cytochrome P450, CYP2 family
Contains IPR017972 Cytochrome P450, conserved site
IPR017973 Cytochrome P450, C-terminal
GO Term annotationHelp
Process GO:0055114 oxidation reduction
Function GO:0004497 monooxygenase activity
GO:0005506 iron ion binding
GO:0020037 heme binding
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

Cytochrome P450 enzymes are a superfamily of haem-containing mono-oxygenases that are found in all kingdoms of life, and which show extraordinary diversity in their reaction chemistry. In mammals, these proteins are found primarily in microsomes of hepatocytes and other cell types, where they oxidise steroids, fatty acids and xenobiotics, and are important for the detoxification and clearance of various compounds, as well as for hormone synthesis and breakdown, cholesterol synthesis and vitamin D metabolism. In plants, these proteins are important for the biosynthesis of several compounds such as hormones, defensive compounds and fatty acids. In bacteria, they are important for several metabolic processes, such as the biosynthesis of antibiotic erythromycin in Saccharopolyspora erythraea (Streptomyces erythraeus).

Cytochrome P450 enzymes use haem to oxidise their substrates, using protons derived from NADH or NADPH to split the oxygen so a single atom can be added to a substrate. They also require electrons, which they receive from a variety of redox partners. In certain cases, cytochrome P450 can be fused to its redox partner to produce a bi-functional protein, such as with P450BM-3 from Bacillus megaterium [1], which has haem and flavin domains.

Organisms produce many different cytochrome P450 enzymes (at least 58 in humans), which together with alternative splicing can provide a wide array of enzymes with different substrate and tissue specificities. Individual cytochrome P450 proteins follow the nomenclature: CYP, followed by a number (family), then a letter (subfamily), and another number (protein); e.g. CYP3A4 is the fourth protein in family 3, subfamily A. In general, family members should share >40% identity, while subfamily members should share >55% identity.

Cytochrome P450 proteins can also be grouped by two different schemes. One scheme was based on a taxonomic split: class I (prokaryotic/mitochondrial) and class II (eukaryotic microsomes). The other scheme was based on the number of components in the system: class B (3-components) and class E (2-components). These classes merge to a certain degree. Most prokaryotes and mitochondria (and fungal CYP55) have 3-component systems (class I/class B) - a FAD-containing flavoprotein (NAD(P)H-dependent reductase), an iron-sulphur protein and P450. Most eukaryotic microsomes have 2-component systems (class II/class E) - NADPH:P450 reductase (FAD and FMN-containing flavoprotein) and P450. There are exceptions to this scheme, such as 1-component systems that resemble class E enzymes [2, 3, 4]. The class E enzymes can be further subdivided into five sequence clusters, groups I-V, each of which may contain more than one cytochrome P450 family (eg, CYP1 and CYP2 are both found in group I). The divergence of the cytochrome P450 superfamily into B- and E-classes, and further divergence into stable clusters within the E-class, appears to be very ancient, occurring before the appearance of eukaryotes.

This entry represents class E cytochrome P450 proteins that fall into sequence cluster group I. Group I is richest in members, consisting of cytochrome P450 families CYP1, CYP2, CYP17, CYP21 and CYP71 [5]. The members of the first four families are of vertebrate origin, while those from CYP71 are derived from plants. CYP1 and CYP2 enzymes mainly metabolise exogenous substrates, whereas CYP17 and CYP21 are involved in metabolism of endogenous physiologically-active compounds.

More information about these proteins can be found at Protein of the Month: Cytochrome P450 [6].

Structural linksHelp
SCOP: a.104.1.1
CATH: 1.10.630.10
Database linksHelp
Enzyme: EC:1.14
Blocks: IPB002401

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR002401 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O17624 Putative cytochrome P450 cyp-13B1

O35084 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial

O46051 Probable cytochrome P450 4d14

P05177 Cytochrome P450 1A2

P21595 Cytochrome P450-DIT2

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR017972 Cytochrome P450, conserved site
IPR001128 Cytochrome P450
IPR008066 Cytochrome P450, E-class, group I, CYP1
IPR017973 Cytochrome P450, C-terminal
IPR002401 Cytochrome P450, E-class, group I
SWISS-MODEL
PDB Chain
ModBase

PublicationsHelp
1. Munro AW, Girvan HM, McLean KJ.
Cytochrome P450--redox partner fusion enzymes.
Biochim. Biophys. Acta 1770 345-59 2007 [PubMed: 17023115]
http://dx.doi.org/10.1016/j.bbagen.2006.08.018
2. McLean KJ, Sabri M, Marshall KR, Lawson RJ, Lewis DG, Clift D, Balding PR, Dunford AJ, Warman AJ, McVey JP, Quinn AM, Sutcliffe MJ, Scrutton NS, Munro AW.
Biodiversity of cytochrome P450 redox systems.
Biochem. Soc. Trans. 33 796-801 2005 [PubMed: 16042601]
http://www.biochemsoctrans.org/bst/033/0796/bst0330796.htm
3. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW.
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.
Pharmacogenetics 14 1-18 2004 [PubMed: 15128046]
http://dx.doi.org/10.1097/00008571-200401000-00001
4. Degtyarenko KN.
Structural domains of P450-containing monooxygenase systems.
Protein Eng. 8 737-47 1995 [PubMed: 8637843]
http://dx.doi.org/10.1093/protein/8.8.737
5. Gotoh O.
Evolution and differentiation of P-450 genes.
255-72 1993
6. McDowall J.
Protein of the Month ? Cytochrome P450.
2006

Additional ReadingHelp
Zhao Y, Sun L, Muralidhara BK, Kumar S, White MA, Stout CD, Halpert JR.
Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4.
Biochemistry 46 2007 11559-67 [PubMed: 17887776]
http://dx.doi.org/10.1021/bi7011614
Sansen S, Hsu MH, Stout CD, Johnson EF.
Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.
Arch. Biochem. Biophys. 464 2007 197-206 [PubMed: 17540336]
http://dx.doi.org/10.1016/j.abb.2007.04.028
Schoch GA, Yano JK, Sansen S, Dansette PM, Stout CD, Johnson EF.
Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.
J. Biol. Chem. 283 2008 17227-37 [PubMed: 18413310]
http://dx.doi.org/10.1074/jbc.M802180200
Nebert DW, Gonzalez FJ.
P450 genes: structure, evolution, and regulation.
Annu. Rev. Biochem. 56 1987 945-93 [PubMed: 3304150]
http://dx.doi.org/10.1146/annurev.bi.56.070187.004501
Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park HW.
Structural analysis of CYP2R1 in complex with vitamin D3.
J. Mol. Biol. 380 2008 95-106 [PubMed: 18511070]
http://dx.doi.org/10.1016/j.jmb.2008.03.065
Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O.
The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.
DNA Cell Biol. 12 1993 1-51 [PubMed: 7678494]
Smith BD, Sanders JL, Porubsky PR, Lushington GH, Stout CD, Scott EE.
Structure of the human lung cytochrome P450 2A13.
J. Biol. Chem. 282 2007 17306-13 [PubMed: 17428784]
http://dx.doi.org/10.1074/jbc.M702361200
Szklarz GD, He YA, Halpert JR.
Site-directed mutagenesis as a tool for molecular modeling of cytochrome P450 2B1.
Biochemistry 34 1995 14312-22 [PubMed: 7578035]
http://dx.doi.org/10.1021/bi00044a008
spacer
spacer
InterPro 23.1